171 related articles for article (PubMed ID: 30004155)
1. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage.
Zhu M; Li Y; Zhou Z
Biochem Biophys Res Commun; 2017 Oct; 492(3):373-378. PubMed ID: 28847725
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis.
Huang J; Yang X; Peng X; Huang W
Biochem Biophys Res Commun; 2017 Nov; 493(2):921-927. PubMed ID: 28943437
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.
Tian S; Chen H; Tan W
Biochem Biophys Res Commun; 2018 May; 499(4):1019-1024. PubMed ID: 29630860
[TBL] [Abstract][Full Text] [Related]
5. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage.
Song M; Wu H; Wu S; Ge T; Wang G; Zhou Y; Sheng S; Jiang J
Biomed Pharmacother; 2016 Dec; 84():1137-1143. PubMed ID: 27780143
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Sun Y; Xu H; Chen X; Li X; Luo B
Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
[TBL] [Abstract][Full Text] [Related]
8. Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death.
Zheng W; Zhou CY; Zhu XQ; Wang XJ; Li ZY; Chen XC; Chen F; Che XY; Xie X
Biomed Pharmacother; 2018 Oct; 106():175-182. PubMed ID: 29958141
[TBL] [Abstract][Full Text] [Related]
9. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
11. Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer.
Lv Z; Yan X; Lu L; Su C; He Y
J Bioenerg Biomembr; 2018 Aug; 50(4):263-270. PubMed ID: 29687367
[TBL] [Abstract][Full Text] [Related]
12. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
[TBL] [Abstract][Full Text] [Related]
13. Suppression of mitochondrial respiration with auraptene inhibits the progression of renal cell carcinoma: involvement of HIF-1α degradation.
Jang Y; Han J; Kim SJ; Kim J; Lee MJ; Jeong S; Ryu MJ; Seo KS; Choi SY; Shong M; Lim K; Heo JY; Kweon GR
Oncotarget; 2015 Nov; 6(35):38127-38. PubMed ID: 26474388
[TBL] [Abstract][Full Text] [Related]
14. Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma.
Yuen JS; Sim MY; Sim HG; Chong TW; Lau WK; Cheng CW; Ong RW; Huynh H
Int J Oncol; 2012 Aug; 41(2):712-20. PubMed ID: 22641227
[TBL] [Abstract][Full Text] [Related]
15. The selective MEK1 inhibitor Selumetinib enhances the antitumor activity of everolimus against renal cell carcinoma in vitro and in vivo.
Zou Y; Wang J; Leng X; Huang J; Xue W; Zhang J; Huang Y
Oncotarget; 2017 Mar; 8(13):20825-20833. PubMed ID: 28212559
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone.
Cheng G; Hardy M; Topchyan P; Zander R; Volberding P; Cui W; Kalyanaraman B
Sci Rep; 2020 Oct; 10(1):17872. PubMed ID: 33087770
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapy.
Wang B; Ao J; Yu D; Rao T; Ruan Y; Yao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):767-773. PubMed ID: 28645610
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic Chemotherapy Sensitizes Renal Cancer to Immune Checkpoint Blockade Therapy in Preclinical Models.
Cui S
Med Sci Monit; 2017 Jul; 23():3360-3366. PubMed ID: 28697172
[TBL] [Abstract][Full Text] [Related]
19. Induction of Mitochondrial Dysfunction and Oxidative Damage by Antibiotic Drug Doxycycline Enhances the Responsiveness of Glioblastoma to Chemotherapy.
Tan Q; Yan X; Song L; Yi H; Li P; Sun G; Yu D; Li L; Zeng Z; Guo Z
Med Sci Monit; 2017 Aug; 23():4117-4125. PubMed ID: 28842551
[TBL] [Abstract][Full Text] [Related]
20. Preclinical activity of cobimetinib alone or in combination with chemotherapy and targeted therapies in renal cell carcinoma.
Zhang L; Xie D; Lei Y; Na A; Zhu L
Future Oncol; 2021 Aug; 17(23):3051-3060. PubMed ID: 33906367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
